Symbols / PFSA Stock $0.51 -0.12% Profusa, Inc.

Healthcare • Medical Devices • United States • NGM
PFSA (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Dr. Ben Chung-Bin Hwang Ph.D.
Exch · Country NGM · United States
Market Cap 2.27M
Enterprise Value 15.30M
Income -35.82M
Sales —
FCF (ttm) -15.14M
Book/sh -21.64
Cash/sh 0.40
Employees —
Insider 10d —
IPO Jul 11, 2025
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S —
P/B -0.02
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio 0.08
Current Ratio 0.17
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -107.01
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA -5.06%
ROE —
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 4.41M
Shs Float 4.30M
Insider Own 2.83%
Instit Own 1.41%
Short Float 0.86%
Short Ratio 0.00
Short Interest 37.65K
52W High 412.50
vs 52W High -99.88%
52W Low 0.41
vs 52W Low 25.46%
Beta 0.26
Impl. Vol. —
Rel Volume 4.61
Avg Volume 4.76M
Volume 21.91M
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.52
Price $0.51
Change -0.12%
About

Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.52
Latest analyst target
3. DCF / Fair value
$-61.78
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.52
Low
—
High
—
Mean
—
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
27.71
+515.69%
4.50
-25.86%
6.07
-35.72%
9.44
Research And Development
2.80
+74.38%
1.61
-21.02%
2.04
-51.51%
4.20
Selling General And Administration
24.90
+732.29%
2.99
-26.65%
4.08
-22.22%
5.24
General And Administrative Expense
24.90
+732.29%
2.99
-26.65%
4.08
-22.22%
5.24
Other Gand A
24.90
+732.29%
2.99
-26.65%
4.08
-22.22%
5.24
Other Operating Expenses
—
-0.10
-122.22%
-0.04
—
Total Expenses
27.71
+515.69%
4.50
-25.86%
6.07
-35.72%
9.44
Operating Income
-27.71
-515.69%
-4.50
+25.86%
-6.07
+35.72%
-9.44
Total Operating Income As Reported
-27.71
-515.69%
-4.50
+25.86%
-6.07
+45.51%
-11.14
EBITDA
-33.30
-592.93%
-4.81
+19.87%
-6.00
+54.64%
-13.22
Normalized EBITDA
-33.64
-600.00%
-4.81
+19.87%
-6.00
+31.23%
-8.72
Reconciled Depreciation
—
—
—
0.72
EBIT
-33.30
-592.93%
-4.81
+19.87%
-6.00
+56.99%
-13.95
Total Unusual Items
0.34
—
—
-4.50
Total Unusual Items Excluding Goodwill
0.34
—
—
-4.50
Special Income Charges
—
—
—
-6.53
Other Special Charges
—
—
—
6.53
Net Income
-35.82
-288.11%
-9.23
+10.22%
-10.28
+49.15%
-20.22
Pretax Income
-35.82
-288.11%
-9.23
+10.22%
-10.28
+49.15%
-20.22
Net Non Operating Interest Income Expense
-5.09
-15.17%
-4.42
-3.29%
-4.28
+31.69%
-6.27
Interest Expense Non Operating
2.52
-43.02%
4.42
+3.29%
4.28
-31.69%
6.27
Net Interest Income
-5.09
-15.17%
-4.42
-3.29%
-4.28
+31.69%
-6.27
Interest Expense
2.52
-43.02%
4.42
+3.29%
4.28
-31.69%
6.27
Other Income Expense
-3.02
-887.58%
-0.31
-525.00%
0.07
+101.60%
-4.50
Other Non Operating Income Expenses
-3.36
-998.69%
-0.31
-525.00%
0.07
+2500.00%
-0.00
Gain On Sale Of Security
0.34
—
—
2.03
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-35.82
-288.11%
-9.23
+10.22%
-10.28
+49.15%
-20.22
Net Income From Continuing Operation Net Minority Interest
-35.82
-288.11%
-9.23
+10.22%
-10.28
+49.15%
-20.22
Net Income From Continuing And Discontinued Operation
-35.82
-288.11%
-9.23
+10.22%
-10.28
+49.15%
-20.22
Net Income Continuous Operations
-35.82
-288.11%
-9.23
+10.22%
-10.28
+49.15%
-20.22
Normalized Income
-36.16
-291.80%
-9.23
+10.22%
-10.28
+34.58%
-15.72
Net Income Common Stockholders
-35.82
-288.11%
-9.23
+10.22%
-10.28
+49.15%
-20.22
Diluted EPS
—
-21.11
+10.22%
-23.52
+49.15%
-46.24
Basic EPS
—
-21.11
+10.22%
-23.52
+49.15%
-46.24
Basic Average Shares
—
0.44
+0.00%
0.44
+0.00%
0.44
Diluted Average Shares
—
0.44
+0.00%
0.44
+0.00%
0.44
Diluted NI Availto Com Stockholders
-35.82
-288.11%
-9.23
+10.22%
-10.28
+49.15%
-20.22
Total Other Finance Cost
2.57
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
3.77
+22.84%
3.07
+62.33%
1.89
+83.61%
1.03
Current Assets
3.76
+1347.69%
0.26
-21.92%
0.33
+108.13%
0.16
Cash Cash Equivalents And Short Term Investments
1.78
+830.89%
0.19
+34.51%
0.14
+82.05%
0.08
Cash And Cash Equivalents
1.78
+830.89%
0.19
+34.51%
0.14
+82.05%
0.08
Cash Financial
1.78
+830.89%
0.19
+34.51%
0.14
+82.05%
0.08
Receivables
—
0.00
-100.00%
0.04
0.00
Accounts Receivable
—
—
—
0.00
Other Receivables
—
—
0.04
—
Prepaid Assets
0.54
+684.06%
0.07
-52.74%
0.15
—
Other Current Assets
1.45
—
—
0.08
Total Non Current Assets
0.01
-99.61%
2.81
+80.32%
1.56
+79.10%
0.87
Net PPE
0.01
0.00
-100.00%
0.00
0.00
Gross PPE
—
0.00
-100.00%
0.00
-99.76%
0.82
Accumulated Depreciation
—
—
—
-0.82
Properties
—
—
—
0.00
Machinery Furniture Equipment
—
—
—
0.78
Other Properties
—
—
0.00
-95.12%
0.04
Leases
—
—
—
0.00
Non Current Deferred Assets
0.00
-100.00%
2.76
+80.55%
1.53
+81.57%
0.84
Other Non Current Assets
0.00
-94.64%
0.06
+80.65%
0.03
+3.33%
0.03
Total Liabilities Net Minority Interest
30.43
-75.11%
122.28
+9.29%
111.89
+11.00%
100.80
Current Liabilities
22.26
-61.04%
57.13
+22.23%
46.74
+31.10%
35.65
Payables And Accrued Expenses
11.25
+106.50%
5.45
+24.32%
4.38
+8.60%
4.04
Payables
9.34
+88.51%
4.95
+24.07%
3.99
+16.48%
3.43
Accounts Payable
7.34
+48.26%
4.95
+24.07%
3.99
+16.48%
3.43
Current Accrued Expenses
1.92
+286.09%
0.50
+26.85%
0.39
-35.80%
0.61
Pensionand Other Post Retirement Benefit Plans Current
4.07
+17.11%
3.47
+77.14%
1.96
+235.62%
0.58
Total Tax Payable
1.95
0.00
—
—
Current Debt And Capital Lease Obligation
6.94
-85.61%
48.21
+19.34%
40.40
+30.18%
31.03
Current Debt
6.94
-85.61%
48.21
+19.34%
40.40
+30.18%
31.03
Other Current Borrowings
5.59
-88.18%
47.30
+19.60%
39.55
+29.85%
30.46
Current Capital Lease Obligation
—
—
—
0.00
Other Current Liabilities
—
—
—
—
Total Non Current Liabilities Net Minority Interest
8.18
-87.45%
65.15
+0.00%
65.15
+0.00%
65.15
Long Term Debt And Capital Lease Obligation
7.88
—
—
0.00
Long Term Debt
7.88
—
—
—
Long Term Capital Lease Obligation
—
—
—
0.00
Preferred Securities Outside Stock Equity
0.00
-100.00%
65.15
+0.00%
65.15
+0.00%
65.15
Stockholders Equity
-26.66
+77.64%
-119.20
-8.37%
-110.00
-10.25%
-99.77
Common Stock Equity
-26.66
+77.64%
-119.20
-8.37%
-110.00
-10.25%
-99.77
Capital Stock
0.00
0.00
0.00
0.00
Common Stock
0.00
0.00
0.00
0.00
Share Issued
1.15
+0.00%
1.15
+163.55%
0.44
+0.00%
0.44
Ordinary Shares Number
1.15
+0.00%
1.15
+163.55%
0.44
+0.00%
0.44
Additional Paid In Capital
134.12
+2231.36%
5.75
+0.37%
5.73
+0.99%
5.68
Retained Earnings
-160.78
-28.67%
-124.96
-7.98%
-115.73
-9.75%
-105.45
Total Equity Gross Minority Interest
-26.66
+77.64%
-119.20
-8.37%
-110.00
-10.25%
-99.77
Total Capitalization
-18.78
+84.24%
-119.20
-8.37%
-110.00
-10.25%
-99.77
Working Capital
-18.49
+67.48%
-56.87
-22.54%
-46.41
-30.75%
-35.49
Invested Capital
-11.84
+83.32%
-71.00
-2.01%
-69.60
-1.25%
-68.74
Total Debt
14.81
-69.27%
48.21
+19.34%
40.40
+30.18%
31.03
Net Debt
13.04
-72.85%
48.02
+19.28%
40.25
+30.04%
30.95
Capital Lease Obligations
—
—
—
0.00
Net Tangible Assets
-26.66
+77.64%
-119.20
-8.37%
-110.00
-10.25%
-99.77
Tangible Book Value
-26.66
+77.64%
-119.20
-8.37%
-110.00
-10.25%
-99.77
Current Notes Payable
1.35
+47.91%
0.91
+7.18%
0.85
+47.40%
0.58
Derivative Product Liabilities
0.30
0.00
—
—
Dueto Related Parties Current
0.04
0.00
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-16.25
-686.45%
-2.07
+53.07%
-4.40
+42.85%
-7.70
Cash Flow From Continuing Operating Activities
-16.25
-686.45%
-2.07
+53.07%
-4.40
+42.85%
-7.70
Net Income From Continuing Operations
-35.82
-288.11%
-9.23
+10.22%
-10.28
+49.15%
-20.22
Depreciation Amortization Depletion
—
—
—
0.72
Depreciation
—
—
—
0.72
Depreciation And Amortization
—
—
—
0.72
Other Non Cash Items
14.68
+209.99%
4.74
+9.99%
4.30
+7.87%
3.99
Stock Based Compensation
0.89
+4142.86%
0.02
-36.36%
0.03
-70.27%
0.11
Operating Gains Losses
-0.90
-44850.00%
0.00
—
6.78
Gain Loss On Investment Securities
-0.90
—
—
-2.03
Unrealized Gain Loss On Investment Securities
0.56
0.00
—
—
Gain Loss On Sale Of PPE
0.00
-100.00%
0.00
0.00
—
Change In Working Capital
4.35
+80.63%
2.41
+56.13%
1.54
+69.53%
0.91
Change In Receivables
0.00
-100.00%
0.04
+200.00%
-0.04
-218.42%
0.04
Change In Prepaid Assets
0.21
+174.03%
0.08
+220.31%
-0.06
-255.56%
-0.02
Change In Payables And Accrued Expense
4.08
+76.79%
2.31
+39.85%
1.65
+23.21%
1.34
Change In Accrued Expense
0.52
-68.63%
1.66
+48.84%
1.12
+76.34%
0.63
Change In Payable
3.56
+451.94%
0.65
+21.01%
0.53
-24.50%
0.71
Change In Account Payable
3.56
+451.94%
0.65
+21.01%
0.53
-24.50%
0.71
Change In Other Current Assets
0.05
+312.00%
-0.03
-2400.00%
-0.00
+96.00%
-0.03
Change In Other Current Liabilities
—
—
—
-0.43
Investing Cash Flow
-2.01
0.00
+100.00%
-0.00
—
Cash Flow From Continuing Investing Activities
-2.01
0.00
+100.00%
-0.00
—
Net PPE Purchase And Sale
-0.01
0.00
+100.00%
-0.00
—
Purchase Of PPE
-0.01
0.00
+100.00%
-0.00
—
Capital Expenditure
-0.01
—
-0.00
—
Net Investment Purchase And Sale
-2.00
0.00
—
—
Purchase Of Investment
-2.00
0.00
—
—
Financing Cash Flow
19.84
+838.20%
2.12
-52.66%
4.47
-35.47%
6.92
Cash Flow From Continuing Financing Activities
19.84
+838.20%
2.12
-52.66%
4.47
-35.47%
6.92
Net Issuance Payments Of Debt
9.56
+210.96%
3.08
-39.20%
5.06
-34.26%
7.70
Issuance Of Debt
12.45
+285.93%
3.23
-38.08%
5.21
-35.31%
8.05
Repayment Of Debt
-2.88
-1823.33%
-0.15
+0.66%
-0.15
+57.82%
-0.36
Long Term Debt Issuance
—
—
—
0.00
Net Long Term Debt Issuance
—
—
—
0.00
Short Term Debt Issuance
12.45
+285.93%
3.23
-38.08%
5.21
-35.31%
8.05
Short Term Debt Payments
-2.88
-1823.33%
-0.15
+0.66%
-0.15
+57.82%
-0.36
Net Short Term Debt Issuance
9.56
+210.96%
3.08
-39.20%
5.06
-34.26%
7.70
Proceeds From Stock Option Exercised
—
0.00
-100.00%
0.02
+35.29%
0.02
Net Other Financing Charges
10.28
+1169.51%
-0.96
-56.51%
-0.61
+22.18%
-0.79
Changes In Cash
1.59
+3138.78%
0.05
-23.44%
0.06
+108.23%
-0.78
Beginning Cash Position
0.19
+34.51%
0.14
+82.05%
0.08
-90.89%
0.86
End Cash Position
1.78
+830.89%
0.19
+34.51%
0.14
+82.05%
0.08
Free Cash Flow
-16.26
-686.83%
-2.07
+53.09%
-4.40
+42.82%
-7.70
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category